Takeyuki Nagashima

867 citations

33 papers · 671 indexed · h-index 13

Co-authors: Teruhiko Shimokawa Masayuki Shibasaki Akiyoshi Shimaya Hirotsugu Tanaka Yasuharu Urano Nobuharu Shigematsu Yoshiki Katayama Osamu Okitsu
Topics: Virus-based gene therapy research (6 papers)Protein Kinase Regulation and GTPase Signaling (6 papers)RNA Interference and Gene Delivery (4 papers)
Cited by: Aging Molecular Biology Geriatrics and Gerontology
Journals: Proceedings of the National Academy of Sciences Cancer Research Biochemical and Biophysical Research Communications
Partner nations: Japan United States India

In The Last Decade

Takeyuki Nagashima

33 papers receiving 662 citations

Peers

Countries citing papers authored by Takeyuki Nagashima

Since Specialization

Citations

This map shows the geographic impact of Takeyuki Nagashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeyuki Nagashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeyuki Nagashima more than expected).

Fields of papers citing papers by Takeyuki Nagashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeyuki Nagashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeyuki Nagashima. The network helps show where Takeyuki Nagashima may publish in the future.

Co-authorship network of co-authors of Takeyuki Nagashima

This figure shows the co-authorship network connecting the top 25 collaborators of Takeyuki Nagashima. A scholar is included among the top collaborators of Takeyuki Nagashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeyuki Nagashima. Takeyuki Nagashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhanced Antitumor Immunity by ASP1570, a Novel Diacylglycerol Kinase ζ Inhibitor, Offers a Potential Novel Immunotherapy for Treating Cancer 2025 ·Molecular Cancer Therapeutics ·Osamu Ikeda,(unknown),(unknown),Hideyuki Watanabe,(unknown),(unknown),(unknown),(unknown),(unknown),Tomoko Kawashima,(unknown),Atsushi Suzuki,Takeyuki Nagashima,(unknown),Kazuya Yamano,Tatsuya Kawase,Taku Yoshida	3
2	Discovery of KRAS(G12D) selective degrader ASP3082 2025 ·Communications Chemistry ·Tomohiro Yoshinari,Takeyuki Nagashima,(unknown),Kohei Inamura,(unknown),(unknown),(unknown),(unknown),(unknown),Ayako Nakayama,Y. Amano,(unknown),(unknown),(unknown),Masayasu Yoshino,(unknown),(unknown),Masahiko Hayakawa	2
3	Discovery of ASP6918, a KRAS G12C inhibitor: Synthesis and structure–activity relationships of 1-{2,7-diazaspiro[3.5]non-2-yl}prop-2-en-1-one derivatives as covalent inhibitors with good potency and oral activity for the treatment of solid tumors 2023 ·Bioorganic & Medicinal Chemistry ·(unknown),Itsuro Shimada,(unknown),(unknown),(unknown),(unknown),(unknown),Y. Amano,Kenichi Mori,(unknown),Ayako Nakayama,(unknown),Masashi Shimazaki,Takeyuki Nagashima,(unknown)	5
4	Discovery and biological evaluation of 1-{2,7-diazaspiro[3.5]nonan-2-yl}prop-2-en-1-one derivatives as covalent inhibitors of KRAS G12C with favorable metabolic stability and anti-tumor activity 2022 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Tomoaki Abe,(unknown),(unknown),(unknown),(unknown),Osamu Kaneko,Y. Amano,Kenichi Mori,Yosuke Yamanaka,Takeyuki Nagashima,Masashi Shimazaki,(unknown)	12
5	Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical models 2021 ·British Journal of Cancer ·Ayako Nakayama,Takeyuki Nagashima,(unknown),(unknown),Kenichi Mori,(unknown),Masatoshi Yuri,Masashi Shimazaki	14
6	Development of a potent and orally active activator of adenosine monophosphate-activated protein kinase (AMPK), ASP4132, as a clinical candidate for the treatment of human cancer 2020 ·Bioorganic & Medicinal Chemistry ·(unknown),Hiroyoshi Yamada,Takashi Shin,Yuki Sawada,(unknown),(unknown),Takeyuki Nagashima,(unknown)	10
7	Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice 2010 ·Molecular Pharmacology ·Takeyuki Nagashima,Nobuharu Shigematsu,(unknown),Yasuharu Urano,Hirotsugu Tanaka,Akiyoshi Shimaya,Teruhiko Shimokawa,Masayuki Shibasaki	221
8	Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice 2010 ·European Journal of Pharmacology ·Hirotsugu Tanaka,Takeyuki Nagashima,Akiyoshi Shimaya,Yasuharu Urano,Teruhiko Shimokawa,Masayuki Shibasaki	27
9	Efficient delivery of siRNA using dendritic poly(l-lysine) for loss-of-function analysis 2007 ·Journal of Controlled Release ·Yusuke Inoue,(unknown),Akiko Tsuchida,(unknown),Takeyuki Nagashima,Takeshi Mori,Takuro Niidome,Yoshiki Katayama,Osamu Okitsu	82
10	CyclinB2 and BIRC5 genes as surrogate biomarkers for neurite outgrowth in SH-SY5Y subclonal cells 2006 ·Neuropharmacology ·Tomoya Oe,Takeyuki Nagashima,(unknown),Takao Yamazaki,Noriyuki Morikawa,Osamu Okitsu,Shintaro Nishimura,Toshiaki Aoki,Yoshiki Katayama,Yasuhiro Kita	7
11	Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling 2006 ·Neuropharmacology ·Takao Yamazaki,(unknown),Tomoya Oe,Noriyuki Morikawa,Osamu Okitsu,Takeyuki Nagashima,Shintaro Nishimura,Yoshiki Katayama,Yasuhiro Kita	43
12	Differences in gene expression profile among SH‐SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor 2005 ·Journal of Neurochemistry ·Tomoya Oe,(unknown),Takeyuki Nagashima,(unknown),Takao Yamazaki,Noriyuki Morikawa,(unknown),Shintaro Nishimura,Toshiaki Aoki,Yoshiki Katayama,Yasuhiro Kita	20
13	Protective effect of FK506 against apoptosis of SH-SY5Y cells correlates with regulation of the serum inducible kinase gene 2005 ·Biochemical Pharmacology ·(unknown),Takao Yamazaki,Noriyuki Morikawa,Osamu Okitsu,Takeyuki Nagashima,Tomoya Oe,Shintaro Nishimura,Yasuhiro Kita	2
14	Mass-tag technology for monitoring of protein kinase activity using mass spectrometry 2004 ·Bioorganic & Medicinal Chemistry Letters ·Tatsuhiko Sonoda,(unknown),Takeyuki Nagashima,Osamu Okitsu,Yasuhiro Kita,Masaharu Murata,Yoshiki Katayama	10
15	High-Level in Vivo Gene Marking after Gene-Modified Autologous Hematopoietic Stem Cell Transplantation without Marrow Conditioning in Nonhuman Primates 2004 ·Molecular Therapy ·(unknown),Yutaka Hanazono,Hiroaki Shibata,Naohide Ageyama,Yasuji Ueda,(unknown),Toshiaki Tabata,Takeyuki Nagashima,Masaaki Takatoku,(unknown),Susumu Ikehara,Masafumi Taniwaki,Keiji Terao,Mamoru Hasegawa,Keiya Ozawa	10
16	Collection and analysis of hematopoietic progenitor cells from cynomolgus macaques (Macaca fascicularis): Assessment of cross‐reacting monoclonal antibodies 2003 ·American Journal of Primatology ·Hiroaki Shibata,Yutaka Hanazono,Naohide Ageyama,Takeyuki Nagashima,Yasuji Ueda,Mamoru Hasegawa,Keiya Ozawa,Yasuhiro Yoshikawa,Keiji Terao	14
17	New selective amplifier genes containing c-Mpl for hematopoietic cell expansion 2003 ·Biochemical and Biophysical Research Communications ·Takeyuki Nagashima,Yasuji Ueda,Yutaka Hanazono,Akihiro Kume,Hiroaki Shibata,Naohide Ageyama,Keiji Terao,Keiya Ozawa,Mamoru Hasegawa	5
18	In vivo expansion of gene‐modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch 2003 ·The Journal of Gene Medicine ·Takeyuki Nagashima,Yasuji Ueda,Yutaka Hanazono,Akihiro Kume,Hiroaki Shibata,Naohide Ageyama,Keiji Terao,Keiya Ozawa,Mamoru Hasegawa	8
19	Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates 2002 ·The Journal of Gene Medicine ·Yutaka Hanazono,Keiji Terao,Hiroaki Shibata,Takeyuki Nagashima,Naohide Ageyama,Takayuki Asano,Yasuji Ueda,Ikunoshin Kato,Akihiro Kume,Mamoru Hasegawa,Keiya Ozawa	14
20	Hsl7p, a negative regulator of Ste20p protein kinase in the Saccharomyces cerevisiae filamentous growth-signaling pathway 1999 ·Proceedings of the National Academy of Sciences ·Atsushi Fujita,Akio Tonouchi,(unknown),(unknown),Takeyuki Nagashima,(unknown),(unknown)	27

About Takeyuki Nagashima

Takeyuki Nagashima is a scholar working on Molecular Biology, Genetics and Hematology, having authored 33 papers that have together received 671 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Aging (17 citations), Molecular Biology (472 citations) and Geriatrics and Gerontology (17 citations). Takeyuki Nagashima has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Teruhiko Shimokawa, Masayuki Shibasaki, Akiyoshi Shimaya, Hirotsugu Tanaka, Yasuharu Urano, Nobuharu Shigematsu, Yoshiki Katayama, Osamu Okitsu, Keiji Terao and Hiroaki Shibata. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact